Paige Analysis: $100M Raised
What is Paige?
Paige builds software that advances the diagnosis, treatment, and biomarker discovery for cancer. Their approach integrates computational pathology to enhance diagnostic accuracy and efficiency. This technology transforms the workflow of pathologists, enabling more informed treatment decisions for patients.
HQ Country
New York, United States
Employees
51-200
Founded
2018
Industry
HealthTech, AI/ML, Biotech
Product Features & Capabilities
- Computational pathology software for enhanced diagnostic accuracy
- AI-driven insights for treatment decision-making
- FDA breakthrough designation for computational pathology products
- Intuitive user interface designed for pathologists
- Lightweight platform minimizing IT burden and costs.
How much Paige raised
1 - $100 million
January 14, 2021Lead Investor: Casdin Capital, Johnson & Johnson Innovation – JJDC, Inc.
